The portfolio maintains a sizable cost advantage over competitors, priced within the second-lowest fee quintile among peers.
Schwab Health Care SWHFX
- NAV / 1-Day Return 25.75 / −0.16 %
- Total Assets 771.8 Mil
-
Adj. Expense Ratio
0.790%
- Expense Ratio 0.790%
- Distribution Fee Level Below Average
- Share Class Type No Load
- Category Health
- Investment Style Large Blend
- Min. Initial Investment —
- Status Open
- TTM Yield 0.79%
- Turnover 53%
USD | NAV as of Apr 18, 2024 | 1-Day Return as of Apr 18, 2024, 11:58 PM GMT+0
Morningstar’s Analysis SWHFX
Will SWHFX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 42.3
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Eli Lilly and Co | 7.25 | 56.4 Mil | Healthcare |
UnitedHealth Group Inc | 5.88 | 45.7 Mil | Healthcare |
Merck & Co Inc | 5.09 | 39.6 Mil | Healthcare |
Novo Nordisk A/S Class B | 4.75 | 36.9 Mil | Healthcare |
Johnson & Johnson | 3.85 | 30.0 Mil | Healthcare |
AbbVie Inc | 3.17 | 24.7 Mil | Healthcare |
Novartis AG Registered Shares | 3.14 | 24.4 Mil | Healthcare |
Abbott Laboratories | 3.12 | 24.3 Mil | Healthcare |
Vertex Pharmaceuticals Inc | 3.11 | 24.2 Mil | Healthcare |
Amgen Inc | 2.96 | 23.1 Mil | Healthcare |